Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High-temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID-19 mRNA vaccines.
Rinchai D, Deola S, Zoppoli G, Kabeer BSA, Taleb S, Pavlovski I, Maacha S, Gentilcore G, Toufiq M, Mathew L, Liu L, Vempalli FR, Mubarak G, Lorenz S, Sivieri I, Cirmena G, Dentone C, Cuccarolo P, Giacobbe DR, Baldi F, Garbarino A, Cigolini B, Cremonesi P, Bedognetti M, Ballestrero A, Bassetti M, Hejblum BP, Augustine T, Van Panhuys N, Thiebaut R, Branco R, Chew T, Shojaei M, Short K, Feng CG; PREDICT-19 Consortium; Zughaier SM, De Maria A, Tang B, Ait Hssain A, Bedognetti D, Grivel JC, Chaussabel D. Rinchai D, et al. Among authors: shojaei m. Sci Adv. 2022 Nov 11;8(45):eabp9961. doi: 10.1126/sciadv.abp9961. Epub 2022 Nov 11. Sci Adv. 2022. PMID: 36367935 Free PMC article.
Biomarkers for high-risk influenza patients: what are the next steps?
Tang BM, Shojaei M, Branley J, McLean A. Tang BM, et al. Among authors: shojaei m. Expert Rev Mol Diagn. 2018 Mar;18(3):205-206. doi: 10.1080/14737159.2018.1420475. Epub 2017 Dec 26. Expert Rev Mol Diagn. 2018. PMID: 29264948 No abstract available.
Prospective validation study of prognostic biomarkers to predict adverse outcomes in patients with COVID-19: a study protocol.
Tang B, Shojaei M, Wang Y, Nalos M, Mclean A, Afrasiabi A, Kwan TN, Kuan WS, Zerbib Y, Herwanto V, Gunawan G, Bedognetti D, Zoppoli G, Ballestrero A, Rinchai D, Cremonesi P, Bedognetti M, Matejovic M, Karvunidis T, Macdonald SPJ, Cox AJ, West NP, Cripps AW, Schughart K, Maria A, Chaussabel D, Iredell J, Weng S; PREDICT-19 consortium. Tang B, et al. Among authors: shojaei m. BMJ Open. 2021 Jan 6;11(1):e044497. doi: 10.1136/bmjopen-2020-044497. BMJ Open. 2021. PMID: 33408218 Free PMC article.
Blood transcriptome responses in patients correlate with severity of COVID-19 disease.
Wang Y, Schughart K, Pelaia TM, Chew T, Kim K, Karvunidis T, Knippenberg B, Teoh S, Phu AL, Short KR, Iredell J, Thevarajan I, Audsley J, Macdonald S, Burcham J, McLean A; PREDICT-19 consortium; Tang B, Shojaei M. Wang Y, et al. Among authors: shojaei m. Front Immunol. 2023 Jan 20;13:1043219. doi: 10.3389/fimmu.2022.1043219. eCollection 2022. Front Immunol. 2023. PMID: 36741372 Free PMC article.
Pathway and Network Analyses Identify Growth Factor Signaling and MMP9 as Potential Mediators of Mitochondrial Dysfunction in Severe COVID-19.
Wang Y, Schughart K, Pelaia TM, Chew T, Kim K, Karvunidis T, Knippenberg B, Teoh S, Phu AL, Short KR, Iredell J, Thevarajan I, Audsley J, Macdonald S, Burcham J, Predict-Consortium, Tang B, McLean A, Shojaei M. Wang Y, et al. Among authors: shojaei m. Int J Mol Sci. 2023 Jan 28;24(3):2524. doi: 10.3390/ijms24032524. Int J Mol Sci. 2023. PMID: 36768847 Free PMC article.
Host transcriptomics and machine learning for secondary bacterial infections in patients with COVID-19: a prospective, observational cohort study.
Carney M, Pelaia TM, Chew T, Teoh S, Phu A, Kim K, Wang Y, Iredell J, Zerbib Y, McLean A, Schughart K, Tang B, Shojaei M, Short KR; PREDICT-19 consortium. Carney M, et al. Among authors: shojaei m. Lancet Microbe. 2024 Mar;5(3):e272-e281. doi: 10.1016/S2666-5247(23)00363-4. Epub 2024 Feb 1. Lancet Microbe. 2024. PMID: 38310908 Free article.
Pathway mapping of leukocyte transcriptome in influenza patients reveals distinct pathogenic mechanisms associated with progression to severe infection.
Zerbib Y, Jenkins EK, Shojaei M, Meyers AFA, Ho J, Ball TB, Keynan Y, Pisipati A, Kumar A, Kumar A, Nalos M, Tang BM, Schughart K, McLean A; Nepean Genomic Research Group. Zerbib Y, et al. Among authors: shojaei m. BMC Med Genomics. 2020 Feb 17;13(1):28. doi: 10.1186/s12920-020-0672-7. BMC Med Genomics. 2020. PMID: 32066441 Free PMC article. Clinical Trial.
119 results